{ "sku": "HLT011", "module": "Clinical Trial Eligibility Engine", "generated_at": "2026-05-17T19:32:31.716145", "seed": 42, "n_patients": 1500, "n_trial_templates": 15, "eligibility": { "overall_rate": 0.78, "mean_score": 0.701, "score_std": 0.177 }, "enrollment": { "total_enrolled": 467, "unique_patients": 467, "trials_meeting_target": 0, "mean_screen_fail_rate": 0.315 }, "endpoints": { "total_assessments": 2689, "responder_rate_active_arm": 0.711, "protocol_deviation_rate": 0.076, "withdrawal_rate": 0.008 }, "trials": [ { "trial_id": "TRIAL-GD-001", "disease": "Gaucher Disease Type 1", "phase": "Phase 3", "n_target": 120 }, { "trial_id": "TRIAL-SMA-001", "disease": "Spinal Muscular Atrophy", "phase": "Phase 3", "n_target": 80 }, { "trial_id": "TRIAL-CF-001", "disease": "Cystic Fibrosis", "phase": "Phase 3", "n_target": 200 }, { "trial_id": "TRIAL-DMD-001", "disease": "Duchenne Muscular Dystrophy", "phase": "Phase 2/3", "n_target": 60 }, { "trial_id": "TRIAL-HD-001", "disease": "Huntington Disease", "phase": "Phase 2/3", "n_target": 100 }, { "trial_id": "TRIAL-FAB-001", "disease": "Fabry Disease", "phase": "Phase 3", "n_target": 90 }, { "trial_id": "TRIAL-MFS-001", "disease": "Marfan Syndrome", "phase": "Phase 3", "n_target": 150 }, { "trial_id": "TRIAL-HEM-001", "disease": "Hemophilia A", "phase": "Phase 3", "n_target": 70 }, { "trial_id": "TRIAL-PKD-001", "disease": "ADPKD", "phase": "Phase 3", "n_target": 180 }, { "trial_id": "TRIAL-OI-001", "disease": "Osteogenesis Imperfecta", "phase": "Phase 2/3", "n_target": 100 }, { "trial_id": "TRIAL-TS-001", "disease": "Tuberous Sclerosis", "phase": "Phase 3", "n_target": 80 }, { "trial_id": "TRIAL-SCD-001", "disease": "Sickle Cell Disease", "phase": "Phase 3", "n_target": 75 }, { "trial_id": "TRIAL-NPC-001", "disease": "Niemann-Pick Type C", "phase": "Phase 2/3", "n_target": 50 }, { "trial_id": "TRIAL-LCA-001", "disease": "Leber Congenital Amaurosis", "phase": "Phase 3", "n_target": 40 }, { "trial_id": "TRIAL-CAH-001", "disease": "Congenital Adrenal Hyperplasia", "phase": "Phase 3", "n_target": 110 } ] }